DANIELLE FORTINI: Open Payments
NPI 1255006557 · LEDGEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 37 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $146 |
| PFIZER INC. | 5 | $94 |
| Novo Nordisk Inc | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| Exact Sciences Corporation | 2 | $44 |
| Corcept Therapeutics | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $19 |
Products named: VRAYLAR, ELIQUIS, UBRELVY, CAPLYTA, Cologuard Collection Kit, PREVNAR 20, Korlym, Wegovy.
Industry payments across NJ — which companies pay providers there.
